维普中文期刊产品整合服务
8篇 您的检索式:作者名="Forrest LD"
    题名 作者 年代 出处 被引量
1Cost effectiveness of ivtooralswitch therapy : azithromycin vs cofuroxime with or without ery-thromycin for the treatment of community acquired pnenmonial 显示文摘Paladino JA Gudgel LD Forrest A 2012Chest2012,122,4:1
2Cost effectiveness of ivtooral switch therapy:Azithromycin vsCefuroximewith orwithout Erythromycin for the treatment of com unity-acquired pneumonia显示文摘Paladino JA Gudgel LD Forrest A 2002Chest2002,122,4:1
3Cost ef-fectiveness of iv-to-oral switch therapy:a zithr om ycin vs co-furoxime with or without erythromycin for the treatment ofcommunity acquired pnenmonia显示文摘PALADINO JA GUDGEL LD FORREST A 2002Chest2002,122,4:1
4Semirational design of a potent, artificial agonist of fibroblast growth factor receptors显示文摘Ballinger MD Shyamala V Forrest LD 1999Nat Biotechnol1999,17,12:1
5Cost effectiveness of iv-to-oral switch therapy:Azithromycin vs Cofuroxime with or without Erythromycin for the treatment of community acquired pnenmonia显示文摘Paladino JA Gudgel LD Forrest A 2002Chest2002,122,4:1
6Cost effectiveness of Ⅳ-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia 显示文摘Paladino JA Gudgel LD Forrest A Niederman MS 2002Chest2002,122,:1
7Semirational design of a potent,artificial agonist of fibroblast growth factor receptors显示文摘Balhnger MD Shyamala V Forrest LD 1999Nat Biotechnol1999,17,12:1
8Azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia显示文摘Paladino JA Gudgel LD Forrest A 2002Chest2002,122,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费